Omeros Corporation (OMER)
Healthcare
Biotechnology
12.60 $
+6.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Omeros Corporation (OMER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -116 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -58 | -65 | -52 | -36 | -104 | -60 | -100 | -110 | -86 | 75 | -149 | -116 | |
| 0.3 | 0.2 | 0.3 | 0.6 | 1.0 | 1.8 | 1.6 | 1.4 | 1.0 | 0.9 | 1.0 | 1.0 | |
| 8.9 | 9.6 | 14 | 13 | 12 | 14 | 15 | 18 | 14 | 12 | 10 | 8.2 | |
| 11 | 12 | 21 | 17 | 18 | 14 | 17 | -293 | 14 | – | – | – | |
| 4.8 | -2.3 | -6.2 | -0.2 | 4.3 | -0.4 | 7.6 | -14 | -119 | 247 | 30 | 34 | |
| 0.0 | 0.2 | 0.1 | 0.4 | 0.6 | 0.3 | 0.3 | 0.3 | 0.1 | 0.4 | 0.2 | 0.1 | |
| 6.2 | -21 | -16 | -38 | 25 | -3.4 | -67 | 194 | -128 | 27 | 82 | 165 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 38 | 82 | 41 | 75 | 6.7 | 62 | 99 | 8.1 | 0.4 | -4.7 | -12 | 0.0 | |
| 11 | 4.9 | 28 | -0.4 | 108 | 1.4 | 93 | 0.3 | 0.0 | -102 | -41 | -89 | |
| 51 | 87 | 69 | 75 | 81 | 61 | 175 | 6.3 | 124 | -106 | 63 | -42 | |
| -1.0 | 1.0 | 0.9 | 1.2 | 2.5 | -2.8 | 7.4 | 90 | -90 | -3.9 | -3.7 | 6.3 | |
| -58 | -65 | -52 | -37 | -104 | -60 | -100 | -110 | -87 | 74 | -149 | -116 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.